Dev Labtech Venture IPO vs Sotac Pharmaceuticals IPO

Comparision between Dev Labtech Venture IPO and Sotac Pharmaceuticals IPO.

IPO Details

Dev Labtech Venture IPO is a SME Book Built Issue IPO proposed to list at BSE SME while Sotac Pharmaceuticals IPO is a SME Book Built Issue proposed to list at NSE SME.

	Dev Labtech Venture IPO	Sotac Pharmaceuticals IPO
Logo
Issue Category	SME	SME
Issue Type	IPO	IPO
Process Type	Fixed Price Issue	Book Built Issue
Listing At	BSE SME	NSE SME
Lead Managers	Beeline Capital Advisors Pvt Ltd	Beeline Capital Advisors Pvt Ltd
Registrar	Link Intime India Private Ltd	Kfin Technologies Limited
Market Maker	Sunflower Broking Private Limited	Sunflower Broking Private Limited
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor		Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Dev Labtech Venture IPO is up to ₹11.22 Cr whereas the issue size of the Sotac Pharmaceuticals IPO is up to ₹33.30 Cr. The final issue price of Dev Labtech Venture IPO is ₹51.00 per share and of Sotac Pharmaceuticals IPO is ₹111.00 per share.

	Dev Labtech Venture IPO	Sotac Pharmaceuticals IPO
Face Value	₹10 per share	₹10 per share
Issue Price (Lower)		₹105.00 per share
Issue Price (Upper)		₹111.00 per share
Issue Price (Final)	₹51.00 per share	₹111.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size	2000 shares	1200 shares
Fresh Issue Size	22,00,000 shares	30,00,000 shares
Fresh Issue Size (Amount)	up to ₹11.22 Cr	up to ₹33.30 Cr
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total	22,00,000 shares	30,00,000 shares
Issue Size Total (Amount)	up to ₹11.22 Cr	up to ₹33.30 Cr

IPO Timetable

Dev Labtech Venture IPO opens on Mar 17, 2023, while Sotac Pharmaceuticals IPO opens on Mar 29, 2023. The closing date of Dev Labtech Venture IPO and Sotac Pharmaceuticals IPO is Mar 21, 2023, and Apr 03, 2023, respectively.

	Dev Labtech Venture IPO	Sotac Pharmaceuticals IPO
Anchor Bid Date		Mar 28, 2023
Issue Open	Mar 17, 2023	Mar 29, 2023
Issue Close	Mar 21, 2023	Apr 03, 2023
Basis Of Allotment (Tentative)	Mar 24, 2023	Apr 10, 2023
Initiation of Refunds (Tentative)	Mar 27, 2023	Apr 11, 2023
Credit of Share (Tentative)	Mar 28, 2023	Apr 12, 2023
Listing date (Tentative)	Mar 29, 2023	Apr 13, 2023
Anchor Lockin End date 1	Apr 23, 2023	May 10, 2023
Anchor Lockin End date 2	Jun 22, 2023	Jul 09, 2023

Financials

Dev Labtech Venture IPO P/E ratio is 32.9, as compared to Sotac Pharmaceuticals IPO P/E ratio of 132.14.

Dev Labtech Venture IPO

Sotac Pharmaceuticals IPO

Financial

Dev Labtech Venture Limited Financial Information (Restated)
Period Ended	Total Assets	Total Revenue	Profit After Tax	Net Worth	Reserves and Surplus	Total Borrowing
31-Mar-20	711.23	1,178.85	0.04	144.80	123.84	154.05
31-Mar-21	713.73	1,228.11	3.65	148.45	127.50	177.53
31-Mar-22	888.24	2,698.01	43.62	192.07	66.35	122.58
30-Sep-22	1,166.65	966.43	64.12	717.86	232.17	114.52
Amount in ₹ Lakhs

Sotac Pharmaceuticals Limited Financial Information (Restated Consolidated)
Period Ended	Total Assets	Total Revenue	Profit After Tax	Net Worth	Reserves and Surplus	Total Borrowing
31-Mar-20	3,038.21	2,882.64	8.75	305.73	75.73	15.13
31-Mar-21	3,469.75	4,894.97	-236.54	249.36	19.36	1,035.80
31-Mar-22	3,525.35	7,337.02	287.86	662.19	432.19	1,134.59
30-Sep-22	6,461.60	3,994.65	46.55	797.41	567.41	2,185.52
Amount in ₹ Lakhs

Promoter Shareholding (Pre-Issue)

92.66%

84.63%

Promoter Shareholding (Post-Issue)

68.01%

P/E Ratio

32.9

132.14

Market Cap

₹42.18 Cr.

₹122.66 Cr.

ROE

6.38%%

ROCE

19.03%%

Debt/Equity

2.74

EPS

RoNW

Shares Offered

In the Dev Labtech Venture IPO retail investors (RII) are offered 10,44,000 shares while in Sotac Pharmaceuticals IPO retail investors are offered 10,44,000 shares. Qualified institutional buyers (QIB) are offered in Dev Labtech Venture IPO and 5,71,800 shares in Sotac Pharmaceuticals IPO.

	Dev Labtech Venture IPO	Sotac Pharmaceuticals IPO
Anchor Investor Reserveration		8,53,200 shares
Market Maker Reserveration	1,12,000 shares	1,50,000 shares
QIB		5,71,800 shares
NII	10,44,000 shares	4,28,400 shares
RII	10,44,000 shares	9,98,400 shares
Employee		0 shares
Others
Total	20,88,000 shares	19,98,600 shares

Bids Received (Subscription)

Dev Labtech Venture IPO subscribed 5.47x in total, whereas Sotac Pharmaceuticals IPO subscribed 1.60x.

	Dev Labtech Venture IPO	Sotac Pharmaceuticals IPO
QIB (times)		1.00x
NII (times)	2.65x	4.04x
Big NII (times)
Small NII (times)
RII (times)	8.24x	0.91x
Employee (times)
Other (times)
Total (times)	5.47x	1.60x

Compare with others

Dev Labtech Venture IPO	Sotac Pharmaceuticals IPO
Sotac Pharmaceuticals IPO	Retina Paints IPO
MOS Utility IPO	A G Universal IPO
Infinium Pharmachem IPO	Pattech Fitwell Tube Components IPO
Maiden Forgings IPO	Sancode Technologies IPO
Command Polymers IPO	Exhicon Events IPO
Nirman Agri Genetics IPO	MOS Utility IPO
Labelkraft Technologies IPO	Infinium Pharmachem IPO
VELS Film International IPO	Maiden Forgings IPO
Bright Outdoor Media IPO	Command Polymers IPO
Prospect Commodities IPO	Dev Labtech Venture IPO

Comments

Add a public comment...